IN8bio (INAB) Institutional Ownership $2.23 +0.07 (+3.24%) Closing price 07/3/2025 03:44 PM EasternExtended Trading$2.17 -0.06 (-2.87%) As of 07/3/2025 04:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for IN8bio (NASDAQ:INAB)CurrentInstitutional OwnershipPercentage92.05%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$252.84MNumber ofInstitutional Sellers(last 12 months)4TotalInstitutional Outflows(last 12 months)$63.77M Get INAB Insider Trade Alerts Want to know when executives and insiders are buying or selling IN8bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data INAB Institutional Buying and Selling by Quarter IN8bio Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/16/2025Alyeska Investment Group L.P.2,079,575$345K0.0%-58.9%2.291% 5/6/2025AIGH Capital Management LLC1,450,000$241K0.1%-76.6%1.784% 5/2/2025Sigma Planning Corp700,680$116K0.0%-32.7%0.862% 2/18/2025BIOS Capital Management LP8,600,001$2.21M2.4%N/A11.865% 2/17/2025Alyeska Investment Group L.P.5,063,291$1.30M0.0%+1,064.5%6.986% 2/17/2025683 Capital Management LLC750,000$193K0.0%-44.5%1.035% 2/14/2025Jane Street Group LLC115,919$30K0.0%+296.7%0.160% 2/12/2025Geode Capital Management LLC515,193$133K0.0%+56.5%0.711% 2/12/2025Franklin Resources Inc.5,696,202$1.47M0.0%N/A7.859% 2/12/2025AIGH Capital Management LLC6,191,865$1.59M0.5%+269.7%8.543% Get the Latest News and Ratings for INAB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IN8bio and its competitors with MarketBeat's FREE daily newsletter. 2/10/2025BIOS Capital Management LP8,600,001$2.21M2.3%N/A11.865% 2/3/2025Sigma Planning Corp1,041,380$268K0.0%+22.3%1.437% 11/4/2024Sigma Planning Corp851,280$230K0.0%+42.0%1.819% 8/7/2024AIGH Capital Management LLC2,127,998$1.80M0.6%-26.0%4.823% 2/12/2024AIGH Capital Management LLC4,098,361$5.22M2.1%N/A12.811% 2/8/2024Texas Capital Bank Wealth Management Services Inc78,624$109K0.0%+85.2%0.246% 2/1/2024Sigma Planning Corp132,230$182K0.0%-53.6%0.413% 1/30/2024Voss Capital LLC341,209$471K0.0%-33.3%1.067% 11/13/2023Rock Creek Group LP151,314$157K0.0%+98.3%0.473% 10/19/2023Voss Capital LLC511,584$532K0.1%+11.7%1.619% 8/11/2023Overbrook Management Corp33,756$52K0.0%N/A0.113% 8/2/2023Sigma Planning Corp279,400$430K0.0%+37.0%0.939% 7/28/2023Voss Capital LLC457,876$705K0.1%+35.5%1.539% 5/8/2023Sigma Planning Corp203,900$265K0.0%+105.6%0.816% 2/13/2023Voss Capital LLC338,019$781K0.2%-10.0%1.380% 11/15/2022Precept Management LLC50,000$101K0.7%N/A0.204% 11/7/2022Warberg Asset Management LLC15,000$30K0.0%N/A0.080% 11/2/2022Voss Capital LLC375,570$759K0.2%-25.7%1.993% 10/28/2022Stonegate Investment Group LLC232,310$469K0.0%-12.8%1.233% 10/24/2022United Asset Strategies Inc.14,000$28K0.0%N/A0.074% 8/15/2022Nantahala Capital Management LLC148,801$359K0.0%-57.8%0.790% 8/13/2022Voss Capital LLC505,635$1.14M0.4%+95.2%2.684% 8/9/2022Stonegate Investment Group LLC266,500$602K0.0%N/A1.415% 5/11/2022Rock Creek Group LP86,032$299K0.0%+87.5%0.457% 4/20/2022Sigma Planning Corp97,750$326K0.0%+241.8%0.520% 2/11/2022Ensign Peak Advisors Inc70,028$307K0.0%N/A0.373% 2/10/2022HighTower Advisors LLC10,000$44K0.0%N/A0.053% 2/2/2022Sigma Planning Corp28,600$126K0.0%N/A0.153% 11/16/2021Voss Capital LLC80,727$555K0.2%N/A0.430% 11/16/2021Capital World Investors800,000$5.52M0.0%N/A4.266% The End of Elon Musk…? (Ad)The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.Click here to see why the "End of Elon" crowd is about to be wrong again.11/15/2021Tudor Investment Corp Et Al63,287$434K0.0%N/A0.337% 11/10/2021B. Riley Financial Inc.257,378$1.76M0.2%N/A1.372% (Data available from 1/1/2016 forward) INAB Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of INAB shares? During the previous two years, 12 institutional investors and hedge funds held shares of IN8bio. The most heavily invested institutionals were BIOS Capital Management LP ($2.21M), Franklin Resources Inc. ($1.47M), Voss Capital LLC ($471K), Alyeska Investment Group L.P. ($345K), AIGH Capital Management LLC ($241K), 683 Capital Management LLC ($193K), and Rock Creek Group LP ($157K).Learn more on IN8bio's institutional investors. What percentage of IN8bio's stock is owned by institutional investors? 92.05% of IN8bio's stock is owned by institutional investors. Learn more on INAB's institutional investor holdings. Which institutional investors have been buying IN8bio's stock? Of the 11 institutional investors that purchased IN8bio's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BIOS Capital Management LP ($17.20M), AIGH Capital Management LLC ($8.62M), Franklin Resources Inc. ($5.70M), Alyeska Investment Group L.P. ($4.63M), Sigma Planning Corp ($517.20K), Geode Capital Management LLC ($185.92K), and Voss Capital LLC ($173.57K). How much institutional buying is happening at IN8bio? Institutional investors have bought a total of 32,756,228 shares in the last 24 months. This purchase volume represents approximately $252.84M in transactions. Which of IN8bio's major shareholders have been selling company stock? The following institutional investors have sold IN8bio stock in the last 24 months: AIGH Capital Management LLC ($5.49M), Alyeska Investment Group L.P. ($2.98M), 683 Capital Management LLC ($600.30K), and Sigma Planning Corp ($340.70K). How much institutional selling is happening at IN8bio? Institutional investors have sold a total of 9,413,549 shares in the last 24 months. This volume of shares sold represents approximately $63.77M in transactions. Related Companies KALA Institutional Ownership ALXO Institutional Ownership ENLV Institutional Ownership GBIO Institutional Ownership TPST Institutional Ownership DARE Institutional Ownership SNYR Institutional Ownership CARA Institutional Ownership PASG Institutional Ownership CVKD Institutional Ownership This page (NASDAQ:INAB) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump's ticking time bombA looming tariff deadline on July 9th could be the spark — but what’s buried inside a recent White House docum...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | SponsoredDalio heeds Buffett’s warning… [$319 million stake in gold]Dalio bought a gold ETF… I don’t recommend that for the average retail investor. The real upside is in profita...Golden Portfolio | SponsoredThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IN8bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share IN8bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.